Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 7/20 | 0.65 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.65 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.65 |
| ▸ | CTSB | P07858 | 1/20 | 0.54 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.52 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29568486 | 0.89 | OPRM1 (0.57) | OPRD1OPRM1OPRK1CTSB | |
| SCHEMBL29569090 | 0.88 | OPRM1 (0.63) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29892587 | 0.87 | OPRD1 (0.68) | OPRD1OPRM1OPRK1CTSB | |
| SCHEMBL30799373 | 0.87 | OPRM1 (0.58) | OPRD1OPRM1OPRK1LTA4H | |
| SCHEMBL29568724 | 0.87 | OPRK1 (0.59) | OPRD1OPRM1OPRK1CTSB | |
| SCHEMBL29612429 | 0.87 | NPY4R (0.60) | OPRD1OPRM1OPRK1PSMB5LTA4H | |
| SCHEMBL7999621 | 0.87 | NPY1R (0.60) | LTA4H | |
| SCHEMBL7999628 | 0.87 | NPY1R (0.60) | LTA4H | |
| SCHEMBL30799344 | 0.87 | OPRM1 (0.67) | OPRD1OPRM1OPRK1CTSBLTA4H | |
| SCHEMBL30799565 | 0.87 | OPRM1 (0.67) | OPRD1OPRM1OPRK1CTSBLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116985-A1 | STAPLED PEPTIDES AND METHODS THEREOF | PARABILIS MEDICINES, INC. | 2024-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116985-A1 | STAPLED PEPTIDES AND METHODS THEREOF | CTNNB1, APC, CTNNA1 | OPRD1 4412/4885OPRM1 4382/4885OPRK1 3407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.